Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2025 Jun 25;15:1640082. doi: 10.3389/fonc.2025.1640082

Correction: High-grade non-muscle invasive urothelial carcinoma in dogs and humans share specific expression of integrin α5β1

Roberta Lucianò 1, Maurizio Colecchia 1,2, Francesca Sanvito 1, Irene Locatelli 3, Chiara Venegoni 3, Alessia Di Coste 3, Davide Danilo Zani 4, Angelica Stranieri 4, Chiara Giudice 4, Antonella Rigillo 5, Matteo Gambini 5, Francesco Montorsi 2,5, Andrea Salonia 2,3, Marco Moschini 3, Massimo Alfano 3,*,†
PMCID: PMC12239014  PMID: 40636686

In the published article, there was an error in the Funding statement. “The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by funding of the Italian Ministry of Health [Ricerca corrente].” The correct Funding statement appears below.

“The author(s) declare that financial support was received for the research and/or publication of this article. This study was funded by the European Union’s Horizon EUROPE; PHIRE project is funded under grant agreement no. 101113193 (https://cordis.europa.eu/project/id/101113193). The funding source had no role in the design of this study, data interpretation, or writing of the manuscript. Views and opinions expressed are those of the author(s) and do not necessarily reflect those of the EU or the EIC.”

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES